Confluent Surgical Company Information

Confluent Surgical, Inc is a wholly owned subsidiary of U.S Surgical, a Tyco Healthcare Company and a leading innovator in the development and commercialization of biomaterials that address intra-operative and post-operative complications. Confluent’s technology platform focuses on four segments within the Biosurgical business including sealants, adhesion barriers, internal and external adhesives, and hemostatic agents.

Confluent’s flagship product, DuraSeal™ Dural Sealant, is the first and only approved cranial dural sealant. Confluent Surgical’s DuraSeal Xact™ Adhesion Barrier & Sealant System, approved for use in the European Union and currently under clinical investigation in the United States,  is the only dual-function hydrogel approved for spinal applications.